Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- RAY-B.ST
- Price
- 218.00
- Stock movement up
- +3.00 (1.40%)
- Company name
- RaySearch Laboratories AB (publ)
- Exchange
- (ST ,
- Currency
- SEK )
- Sector
- Healthcare >Health Information Services
- Market cap
- 5.80B
- Ent value
- 6.58B
- Price/Sales
- 4.97
- Price/Book
- 7.16
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- 24.77%
- Trailing P/E
- 33.16
- Forward P/E
- -
- PEG
- -
- EPS growth
- 0.76%
- 1 year return
- 84.75%
- 3 year return
- 67.55%
- 5 year return
- 29.18%
- 10 year return
- 11.08%
Last updated: 2025-04-12
DIVIDENDS
RAY-B.ST does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 33.16 |
| Price to OCF | 11.65 |
| Price to FCF | 20.97 |
| Price to EBITDA | 17.34 |
| EV to EBITDA | 19.67 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 4.97 |
| Price to Book | 7.16 |
| EV to Sales | 5.63 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 26.63M |
| EPS (TTM) | 5.11 |
| FCF per share (TTM) | 8.07 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 1.17B |
| Gross profit (TTM) | 916.09M |
| Operating income (TTM) | 229.67M |
| Net income (TTM) | 175.06M |
| EPS (TTM) | 5.11 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 78.37% |
| Operating margin (TTM) | 19.65% |
| Profit margin (TTM) | 14.97% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 425.03M |
| Net receivables | 0.00 |
| Total current assets | 906.55M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 2.02B |
| Accounts payable | 28.16M |
| Short/Current long term debt | 477.39M |
| Total current liabilities | 699.74M |
| Total liabilities | 1.20B |
| Shareholder's equity | 810.66M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 498.11M |
| Capital expenditures (TTM) | 221.35M |
| Free cash flow (TTM) | 276.76M |
| Dividends paid (TTM) | 68.57M |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 21.59% |
| Return on Assets | 8.69% |
| Return on Invested Capital | 19.61% |
| Cash Return on Invested Capital | 31.00% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 217.00 |
| Daily high | 219.00 |
| Daily low | 212.00 |
| Daily Volume | 62K |
| All-time high | 282.00 |
| 1y analyst estimate | 260.00 |
| Beta | 1.34 |
| EPS (TTM) | 5.11 |
| Dividend per share | - |
| Ex-div date | 23 May 2024 |
| Next earnings date | 9 May 2025 |
Downside potential
Loading...
Downside potential data
| RAY-B.ST | S&P500 | |
| Current price drop from All-time high | -22.70% | -12.89% |
| Highest price drop | -97.28% | -56.47% |
| Date of highest drop | 17 Jul 2003 | 9 Mar 2009 |
| Avg drop from high | -60.41% | -11.07% |
| Avg time to new high | 109 days | 12 days |
| Max time to new high | 4528 days | 1805 days |
COMPANY DETAILS
Marketcap
5.80B
Marketcap category
Mid-cap
Description
RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer care in the Americas, Europe, Africa, the Asia-Pacific, and the Middle East. It develops and markets RayStation, a treatment planning system for radiation therapy; RayCare, an oncology information system that manages clinical activities; RayIntelligence, a cloud-based analytics system for monitoring and enhancement of cancer therapy; and RayCommand, a treatment control system that serves as link between the treatment machine and the treatment planning and oncology information systems. The company offers RayPlan, a treatment planning system for supporting a range of treatment planning activities for 3D-CRT, IMRT, VMAT, and electron beam radiation therapy; and µ-RayStation, a software platform for planning and evaluation in small animal irradiation research. The company (publ) is headquartered in Stockholm, Sweden.
Employees
411
Investor relations
-
SEC filings
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found